In this episode, Jakob Emerson, Associate News Director at Becker’s Healthcare, joins Scott Becker to discuss the challenges surrounding GLP-1 drugs in the insurance space and the varied responses to Medicare Advantage headwinds. They explore Elevance Health’s strategies and share insights into how large and small insurers are navigating these issues.
Insights on GLP-1 Drugs and Medicare Advantage Trends with Jakob Emerson, Becker’s Healthcare
Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.